Week 445 Review - Yet another loss as Optibiotix continues to slide

A mixed week, with some big losses and some reasonable gains. Unfortunately one of the biggest losses was OPTI:Optibiotix dropping 2p. That would normally cost me over £4,000, but thanks to rallies elsewhere the deficit between cost and value only widened by £3,014 to £103,915 and the deficit to injection amount increased to £40,405. Total portfolio value is now less than half the cost, at £102,122.

The biggest percentage loser was BLU:Blue Star Capital which fell 11% but that hardly cost me anything.

AFC:AFC Energy is rivaling CWR:Ceres Power as my worst timed purchase, falling 10% to go 19% down in just a few weeks.

OPTI:Optibiotix fell 2p which is 8% and will keep falling until there is some tangible news.

FXPO:Ferrexpo has been on a bit of a rally recently, but it's all over now as the price dropped 7%.

SBTX:SkinBioTherapeutics has also been a disaster given I invested heavily a few months ago. It fell another 5% this week and like OPTI will continue to slide in the absence of good news.

UKW:Greencoat UK Wind almost went into profit a few months ago, but has plummeted ever since and fell 5% to go 21% down this week.

CAPD:Capital unexpectedly climbed 6% this week but is still 21% down.

CAML:Cental Asia Metals went up by 8% so clearly it knows I want the price to stay lower while my pension transfer comes through, but I will still buy at these levels and quite a bit higher.

JLP:Jubilee Metals has been utterly dreadful recently, but a late rally on Friday saw them go up 8% and claw back some of my significant losses.

Share of the Week is IPX:Impax Asset Management which climbed 9% after dropping 9% last week, but it went ex-dividend last week so has gained that back very quickly and gone 2% into profit.

Here's the ISA and shares portfolio after week 29 of year 9.

			Weekly Change
Cash	£63.26		+£0.42
Portfolio cost	£99,231.92		+£0
Portfolio sell value (bid price-commission)	£46,297.72	(-53.3%)	-£1,804.52
Potential profits	£1,541.22		-£396.38
Yr 9 Dividends	£202.72		+£0
Yr 9 Interest	£3.71		+£0.42
Yr 9 Profit from sales	£11.13		+£0
Yr 9 proj avg monthly profit	£25.63	(0.4%)	-£0.85
Total Dividends	£12,114.15		+£0
Total Interest	£5.64		+£0.42
Total Profit from sales	£17,309.66		+£0
Average monthly cash profit	£282.45	(4.8%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I got 42p interest. OPTI:Optibiotix is my only profitable share and that dropped, so £396 fell from profits which was the same amount I lost last week. Nothing else changed other than losing £1,804 in value.

Not at all good

At least the trend line is safe for a few more months, but I'm dragging it flatter every week.

The SIPP looks like this after week 429 overall and week 13 of year 9.

			Weekly Change
Cash	£152.31		-£247.19
Portfolio cost	£104,513.73		+£247.33
Portfolio sell value (bid price - commission)	£54,387.93	(-48.0%)	-£1,245.84
Potential profits	£936.58		+£158.48
Yr 9 Dividends	£105.13		+£0
Yr 9 Interest	£1.24		+£0.14
Yr 9 Profit from sales	£3,373.97		+£0
Yr 9 proj avg monthly profit	£1,142.35	(19.8%)	-£95.14
Total Dividends	£14,740.01		+£0
Total Interest	£7.17		+£0.14
Total Profit from sales	£14,209.87		+£0
Average monthly cash profit	£280.27	(4.9%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I did my last monthly investment into AJB:AJ Bell buying 77 shares at 317.6808p costing £247.33. That takes my holding to 330 shares at an average price of 298.5048p costing £996.00. They are 2% up so feeling positive. I need to decide what to invest in for the next 4 months!

Potential profits rose thanks to small increases in 5 of my profitable shares, and IPX:Impax Asset Management and one of my JLP:Jubilee Metals holdings going into profit.

Same as the ISA

Not quite as bad as the ISA. I guess as I switch into dividend paying shares the two accounts will start to drift apart, as they have always mirrored one another as I bought similar shares in each.

The trading account looks like this after week 395 overall and week 31 of year 8.

			Weekly Change
Cash	£0.07		+£0
Portfolio cost	£2,076.23		+£0
Portfolio sell value (bid price - commission)	£1,220.97	(-41.2%)	+£35.44
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£40.89	(+23.6%)	-£1.37
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.34	(-3.7%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

BARC:Barclays and JLP:Jubilee Metals both went up but SBTX:SkinBioTherapeutics went down. It's nice to have a positive week but it didn't make up for last week's losses.

Hope it's not just a blip

The trend line is now pointing firmly downwards and we're still below it.

Here's where I try and write something optimistic for what might happen next week, but given we've been waiting since August for "the board to get back off their holidays" and still have no OPTI:Optibiotix contract, I won't bother.